S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
OTCMKTS:EVTCY

Evotec (EVTCY) Stock Forecast, Price & News

$11.67
+0.49 (+4.38%)
(As of 06/2/2023 ET)
Compare
Today's Range
$11.54
$11.67
50-Day Range
$8.95
$11.19
52-Week Range
$14.22
$26.57
Volume
16,511 shs
Average Volume
2,407 shs
Market Capitalization
$3.85 billion
P/E Ratio
28.46
Dividend Yield
N/A
Price Target
N/A

EVTCY stock logo

About Evotec (OTCMKTS:EVTCY) Stock

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.

Receive EVTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evotec and its competitors with MarketBeat's FREE daily newsletter.

EVTCY Stock News Headlines

Is There Now An Opportunity In Evotec SE (ETR:EVT)?
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Evotec SE ADR (EVO) Earnings Dates & Reports
Evotec SE ADR (EVO)
Evotec SE Provides Update on Cyber Attack
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Evotec Q1 Adj. EBITDA Down, Revenues Up
Evotec SE reports FY results
Evotec Confirms Goals Of Action Plan 2025
See More Headlines

EVTCY Price History

EVTCY Company Calendar

Today
6/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:EVTCY
Employees
3,572
Year Founded
1993

Profitability

Net Income
$7.14 million
Pretax Margin
23.90%

Debt

Sales & Book Value

Annual Sales
$572.16 million
Cash Flow
$0.11 per share
Book Value
$2.52 per share

Miscellaneous

Free Float
N/A
Market Cap
$3.85 billion
Optionable
Not Optionable
Beta
0.98

Social Links


Key Executives

  • Werner Lanthaler
    Chief Executive Officer
  • Craig L. Johnstone
    Chief Operating Officer & Member-Management Board
  • Enno Spillner
    Chief Financial Officer
  • Cord E. Dohrmann
    Chief Scientific Officer
  • Volker Braun
    SVP, Head-Investor Relations & ESG













EVTCY Stock - Frequently Asked Questions

How have EVTCY shares performed in 2023?

Evotec's stock was trading at $8.09 at the start of the year. Since then, EVTCY stock has increased by 44.3% and is now trading at $11.67.
View the best growth stocks for 2023 here
.

When did Evotec's stock split?

Evotec shares split on the morning of Wednesday, October 20th 2021. The 3-1 split was announced on Wednesday, October 20th 2021. The newly minted shares were issued to shareholders after the market closes on Wednesday, October 20th 2021. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

What is Evotec's stock symbol?

Evotec trades on the OTCMKTS under the ticker symbol "EVTCY."

How do I buy shares of Evotec?

Shares of EVTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Evotec's stock price today?

One share of EVTCY stock can currently be purchased for approximately $11.67.

How much money does Evotec make?

Evotec (OTCMKTS:EVTCY) has a market capitalization of $3.85 billion and generates $572.16 million in revenue each year. The company earns $7.14 million in net income (profit) each year or $0.41 on an earnings per share basis.

How many employees does Evotec have?

The company employs 3,572 workers across the globe.

Does Evotec have any subsidiaries?
The following companies are subsidiares of Evotec: Aptuit, Bionamics GmbH, Cell Culture Service GmbH, Central Glass Germany, Central Glass Germany. GmbH, Compound Focus, Cyprotex, Develogen AG, Euprotec, Evotec (India) Private Ltd, GlaxoSmithKine's the Verona site, Just-Evotec Biologics, KINAXO Biotechnologies, Oxford Asymmetry International, RENOVIS, and Rigenerand Srl.
Read More
How can I contact Evotec?

Evotec's mailing address is Manfred Eigen Campus Essener Bogen 7, Hamburg 2M, 22419. The official website for the company is www.evotec.com. The company can be reached via phone at (494) 056-0810, via email at investorrelations@evotec.com, or via fax at 49-40-5608-1222.

This page (OTCMKTS:EVTCY) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -